With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...
Innovations in the industry are enticing investors to buy biotech stocks.
If you've made your mobile or startup company public, meeting the expectations of your stockholders is important. Here's how you can even surpass them.
Mergers and acquisitions remain slow in the U.K. Yet, innovative investors in the fintech and media industries have capitalized on Brexit opportunities.
Many analysts expect the market to make a comeback this year, but their views on what would prompt the recovery are mixed.